Clinical Trial: Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients - A Pilot Study
Brief Summary: Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients
Detailed Summary:
Sponsor: Seoul National University Hospital
Current Primary Outcome: Seizure frequency reduction [ Time Frame: 3 month of vigabatrin administration ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Modified Rankin Scale [ Time Frame: 3 month of vigabatrin administration ]
- Quality of life (Quality of Life in Epilepsy Inventory, QOLIE-31) [ Time Frame: after 3 month of vigabatrin administration ]
- Depression (Beck Depression Inventory®-II) [ Time Frame: 3 month of vigabatrin administration ]
- Cognition (Mini-Mental State Examination-Korean) [ Time Frame: 3 month of vigabatrin administration ]
- Sleep quality (Pittsburgh Sleep Quality Assessment) [ Time Frame: 3 month of vigabatrin administration ]
Original Secondary Outcome: Same as current
Information By: Seoul National University Hospital
Dates:
Date Received: December 13, 2016
Date Started: November 2016
Date Completion:
Last Updated: December 23, 2016
Last Verified: December 2016